Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly EBITDA Margin of 5.76% for Q1 2026, up 171.0% year-over-year from 2.13% in Q1 2025, and up 133.58% quarter-over-quarter from 17.15% in Q4 2025.
Bio-Rad Laboratories (BIO) EBITDA Margin (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported EBITDA Margin for 18 consecutive years, with 5.76% the latest figure, recorded in Q1 2026.
- In Q1 2026, EBITDA Margin rose 171.0% year-over-year to 5.76%; the TTM figure through Mar 2026 stood at 2.22% (down 754.0% YoY), while the FY2025 annual figure was 1.83%, down 865.0% from the prior year.
- EBITDA Margin advanced to 5.76% in Q1 2026 per BIO's latest filing, from 17.15% in the prior quarter.
- Across five years, EBITDA Margin topped out at 20.91% in Q1 2022 and bottomed at 17.15% in Q4 2025.
- Historically, EBITDA Margin has averaged 10.35% across 5 years, with a median of 11.83% in 2025.
- Annual changes were most pronounced in 2022 — EBITDA Margin jumped 703 bps — and 2025, when it plunged 2589 bps.
- Bio-Rad Laboratories' EBITDA Margin stood at 16.25% in 2022, then fell by 14 bps to 13.99% in 2023, then plunged by 38 bps to 8.73% in 2024, then plunged by 296 bps to 17.15% in 2025, then surged by 134 bps to 5.76% in 2026.
- Business Quant data shows BIO's EBITDA Margin at 5.76% in Q1 2026, 17.15% in Q4 2025, and 10.0% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 13.44% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 25.18% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 19.10% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 21.65% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 29.48% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 24.33% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 13.96% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 10.30% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 19.15% |
| 10 | Bio-Rad Laboratories | 10.09 Bn | 8.47 Bn | 345.80 Mn | 11.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 11.15% |
| Mar 31, 2026 | 5.76% |
| Dec 31, 2025 | -17.15% |
| Sep 30, 2025 | 10.00% |
| Jun 30, 2025 | 11.83% |
| Mar 31, 2025 | 4.05% |
| Dec 31, 2024 | 8.73% |
| Sep 30, 2024 | 9.93% |
| Jun 30, 2024 | 15.90% |
| Mar 31, 2024 | 7.30% |
| Dec 31, 2023 | 13.99% |
| Sep 30, 2023 | 14.39% |
| Jun 30, 2023 | 13.16% |
| Mar 31, 2023 | 9.15% |
| Dec 31, 2022 | 16.25% |
| Sep 30, 2022 | 13.90% |
| Jun 30, 2022 | 17.78% |
| Mar 31, 2022 | 20.91% |
| Dec 31, 2021 | 16.09% |
| Sep 30, 2021 | 20.99% |